Editor’s Note “What problem does your OR have that you would like to solve?” posed Pamela Hunt, BS, MSN, RN, NEA-BC, FAAN, Executive Advisory, Consultant and Associate Faculty, Kelly School of Business, Indiana University, to the audience at the OR Business Management Conference. During her session, "No Margin, No Mission:…

Read More

Editor's Note This study led by researchers at Loyola University Medical Center, Maywood, Illinois, and Edward Hines Jr Veterans Administration Hospital, Hines, Illinois, finds that core general surgery cases performed by senior-level residents can be done safely without the attending surgeons scrubbed in. Of 109,707 patients analyzed, 11,181 had procedures…

Read More

Editor's Note The Joint Commission on February 1 announced a new search site that is available for finding Joint Commission-accredited organizations that provide substance use disorder (SUD) treatment and the levels of care they provide. Individuals seeking care, providers, state authorities, and payers can search by organization name or location…

Read More

Editor's Note This study from the Netherlands finds the addition of postoperative visits by anesthesia personnel (anesthesiologists or residents) to routine monitoring with modified early warning scores (MEWS) did not reduce 30-day mortality. A total of 5,190 (2,490 control, 2,700 intervention) medium- to high-risk elective surgical patients from nine academic…

Read More

Editor's Note The Food and Drug Administration (FDA) on January 30 identified the recall by Medtronic of its Mahurkar Acute Dual Lumen High Flow (13.5 French) Hemodialysis Catheters (Mahurkar QPlus) as Class I, the most serious. The recall was initiated because of a potential catheter hub defect that may cause…

Read More

Editor's Note This study led by researchers from the University of Michigan, Ann Arbor, finds that characteristics of patients’ neighborhoods and hospitals where they received treatment were both associated with postoperative mortality. This analysis included 1,898,829 Medicare beneficiaries from all neighborhood types undergoing one of five common surgical procedures in…

Read More

Editor's Note The Food and Drug Administration (FDA) on January 27 posted an addition to the Class I recall by LivaNova (TandemLife) of its LifeSPARC System Controller. The addition to the recall provides information about a software update now available to address the previous software malfunction and recall. The System…

Read More

Editor's Note A study done by investigators from Yale, Harvard, and the University of California-San Francisco, published on January 10 in JAMA, found that “many medical devices subject to recall had received Food and Drug Administration (FDA) approval based, in part, on the products’ similarities to earlier devices,” Healthcare Purchasing…

Read More

Editor's Note The Food and Drug Administration (FDA) on January 25 identified the recall by Datascope/Gettinge of its Cardiosave Hybrid and Rescue Intra-Aortic Balloon Pumps (IABPs) as Class I, the most serious. The recall was initiated because of the risk that blood may enter the pump through a damaged balloon…

Read More

Editor's Note This study by researchers from Harvard Medical School, Boston, finds that telehealth is a comparable alternative to in-person care of patients with opioid use disorder (OUD). This cohort study analyzed data on 1,768 clinicians who treated 11,801 patients with OUD via telehealth visits during COVID-19 prepandemic (March 14,…

Read More